Recent Material Events - Cadence Pharmaceuticals, Inc (CADX)

Filing Date	Description
2008-08-07	In accordance with General Instruction B.2. of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ( ...
2008-07-31	The conference call transcript is attached hereto as Exhibit 99.1 and is incorporated herein by reference. A webcast replay of the conference call will remain available on Cadence’s website, www.cadencepharm.com, for fifteen days. ...
2008-03-21	1. Bonuses Payable to Executive Officers for Fiscal 2007 . On March 18, 2008, the Compensation Committee of the Board of Directors (the “Compensation Committee”) of Cadence Pharmaceuticals, Inc. (the “Company”) approved cash bonus ...
2008-02-15	On February 14, 2008, Cadence Pharmaceuticals, Inc. (“Cadence”) entered into common stock purchase agreements with certain investors relating to a registered direct offering of up to 9,240,307 shares of Cadence’s common stock at a purc ...
2008-02-04	Theodore R. Schroeder, President and Chief Executive Officer of Cadence Pharmaceuticals, Inc. (“Cadence”), and other executive officers will be presenting the information attached as Exhibit 99.1 to this Current Report on Form 8-K commencin ...
2007-11-16	Cadence Pharmaceuticals, Inc. hosted a conference call on November 15, 2007, at 8:30 a.m. Eastern time to discuss its third quarter 2007 financial results and provide an update on the clinical development programs for its two Phase III product candid ...
2007-11-14	On November 14, 2007, Cadence Pharmaceuticals, Inc. issued a press release and on November 15, 2007 is holding a conference call announcing its financial results for the three and nine months ended September 30, 2007. A copy of this press release is ...
2007-03-13	On March 13, 2007, Cadence Pharmaceuticals, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2006. A copy of this press release is attached hereto as Exhibit 99.1.... ...
2007-01-30	(e) On January 24, 2007, the compensation committee (the “Committee”) of the Board of Directors of Cadence Pharmaceuticals, Inc. (the “Company”) established performance goals for the payment of bonuses for the 2007 fiscal year und... ...
2006-12-01	On November 29, 2006, Cadence Pharmaceuticals, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2006. A copy of this press release is attached hereto as Exhibit 99.1.... ...